Physician profile
Scott E Litwiller
NPI 1558382028
$27,007.53
in general payments reported to CMS, 2019-2025
46 companies · $944 in 2025
The $944 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,905 · 2020: $2,394 · 2021: $6,767 · 2022: $6,013 · 2023: $1,689 · 2024: $1,295 · 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,671 · Honoraria: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,671.10 |
| Honoraria | $257.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $10,975.92 | 2020-2024 | Axonics |
| Astellas Pharma US INC | $8,688.49 | 2019-2024 | Xtandi |
| Sumitomo Pharma America, INC. | $850.50 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $557.93 | 2019-2025 | Erleada |
| Medtronic USA, INC. | $482.01 | 2019 | |
| Boston Scientific Corporation | $450.17 | 2019-2025 | Axonics, Advantage System |
| Urovant Sciences INC | $430.65 | 2021-2022 | |
| Coloplast Corp | $396.35 | 2020-2024 | Speedicath |
| Pfizer INC. | $393.07 | 2019-2025 | |
| Valencia Technologies Corporation | $371.68 | 2022-2024 | Ecoin Device Kit |
| Allergan, INC. | $368.23 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $332.41 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Caldera Medical, INC | $277.53 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $246.73 | 2019-2024 | |
| Tolmar Pharmaceuticals, INC. | $218.30 | 2019-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Litwiller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.